Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap5.14B
Enterprise Value5.07B
P/E Ratio-22.32
PEG Ratio-0.33
Price/Sales Ratio10.19
Price/Book Ratio1.23
Enterprise/Revenue10.07
Enterprise/EBITDA-585.36

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.46
Operating Margin-0.11
AD

Management Effectiveness

Return On Assets-0.05
Return On Equity-0.05

Income Statement

Revenue404.72M
Revenue/Share0.81
Gross Profit263.53M
EBITDA60.09M
Net Income14.57M
Diluted EPS0.03

Balance Sheet

Total Cash1.47B
Total Cash/Share3.06
Total Debt14.26M
Total Debt/Equity0
Current Ratio21.23
Book Value Per Share6.71

Price History

52-Week Change-34.13
52-Week High13.8
52-Week Low7.77
Moving Average 50 Days9.32
Moving Average 200 Days10.31

Statistics

Average Volume12.13M
Shares Outstanding481.67M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.03
Trailing Annual Dividend Yield0.36
Payout Ratio-0
Last Split Factor2:1
Last Split DateJune 29, 2018
AD